{"id":"W1983180167","doi":"10.1007/s10637-009-9367-9","title":"Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial","year":2009,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Pharmaceuticals Bayer","keywords":"Sorafenib; Medicine; Discontinuation; Rash; Adverse effect; Placebo; Randomized controlled trial; Internal medicine; Soft tissue sarcoma; Nausea; Surgery; Sarcoma; Tolerability; Oncology; Soft tissue; Pathology; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001568595,0.000144476,0.0006322972,0.0001077855,0.00002913398,0.000005182789,0.00004037101,0.00004836358,0.00004387025],"category_scores_gemma":[0.0003782469,0.0001054177,0.00005593772,0.000168871,0.0001545154,0.0001088181,0.00001273758,0.00006402095,8.62974e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003467254,"about_ca_system_score_gemma":0.0001757139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001732551,"about_ca_topic_score_gemma":0.000020835,"domain_scores_codex":[0.9986706,0.00008405797,0.0005638788,0.0002149309,0.0003599435,0.0001065633],"domain_scores_gemma":[0.9987995,0.0005506658,0.000293199,0.0001391352,0.00009559431,0.0001218885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8544557,0.006479762,0.02246726,0.000015325,0.0001808078,0.000007482394,0.0027337,0.00005895913,0.001405709,0.001338082,0.0001247493,0.1107324],"study_design_scores_gemma":[0.7874567,0.001762916,0.202838,0.0002826473,0.0001651236,5.053938e-7,0.00002219448,0.00009344079,0.004350295,0.002845542,0.00009590542,0.0000867827],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954077,0.0003996101,0.00006982665,0.002010736,0.00002796776,0.001914728,0.0001059202,0.00001055181,0.00005298464],"genre_scores_gemma":[0.9940791,0.00002192161,0.004682433,0.0001711729,0.00004804783,0.00003928086,0.0009268559,0.00000866432,0.00002258175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1803707,"threshold_uncertainty_score":0.429881,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01175126435780694,"score_gpt":0.278792244268608,"score_spread":0.2670409799108011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}